Investors aiming for UK life sciences real estate must prepare for a distinct set of assumptions, writes Artem Korolev There is no doubt that the trends shaping real estate investment in the UK are, at least in part, inspired by the US. Take life sciences as a recent example. The success of early-movers, such as Alexandria […]
In May Mission Street and BGO ran a photography competition entitled ‘Tomorrow’s World’ for students and alumni. The response was fantastic with over 200 images submitted showcasing a highly broad interpretation of the theme! Ten images have been shortlisted and professionally framed and hung at Inventa, Oxford, significantly enhancing the arrival experience. A huge thank […]
Joint venture partners Mission Street and investment manager BentallGreenOak (BGO) have signed the first tenant at Inventa, their newly completed purpose-built commercial science scheme in central Oxford. Biotechnology firm Nucleome Therapeutics has agreed to take 20,000 sq ft offitted labs and offices at the 65,000 sq ft building. Located at Botley Road, Inventa is the […]
Mission Street and BGO’s Inventa and Fabrica will be the first Sciences developments of a wider 2.5m sq ft pipeline of academic and commercial Science buildings creating the only Innovation District within walking distance of Oxford station and Oxford city’s world class academic, cultural and amenity offerings. https://oxfordwestend.co.uk/discover/
Artem Korolev discussed how to nurture and facilitate a world-class innovation system. https://www.youtube.com/watch?v=jL-16hnWVTw&list=PLRIcKUhnlDtg92I1zL24mHMkGHQLxb3tH&index=12&t=353s
Mission Street and BGO have secured a resolution to grant planning permission from Oxford City Council for Phase 2 of their development in the West End of Oxford. Known as Fabrica, the scheme will provide 180,000 sq ft of innovation real estate within a 10-minute walk from Oxford station and city centre. Designed by NBBJ, […]
